Glioblastoma: Medical Treatments
Commons · Question 118682 · Tabled 9 Mar 2026 · Department of Health and Social Care · Official record
Answered 18 Mar 2026
Question
Asked by Sir Iain Duncan Smith
To ask the Secretary of State for Health and Social Care, what new personalised treatments for glioblastoma are being assessed.
Answer
Answered by Zubir Ahmed, 18 Mar 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for assessing new medicines to ensure they meet the required standards of quality, safety, and efficacy before they can be authorised for use in the United Kingdom. The MHRA con...